In this Issue:
Low HBV testing & treatment rates in US veterans
What limits CTL-mediated liver injury?
Liver disease progression in HCV-infected alcohol abusers
Antivirals in HCV-related cirrhosis: the impact of SVR
DAAs effective in HCV-related decompensated cirrhosis
Early viral kinetic analysis for optimal therapeutic outcomes?
Retreat NS5A inhibitor failures with sofosbuvir+simeprevir
3-DAA regimen for HCV GT1 and chronic kidney disease
Effects of cirrhosis on survival in HBV-related HCC
Does HEV cause hepatic decompensation in advanced HCV?
Please login below to download this issue (PDF)